Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant

Allergy. 2006 Dec;61(12):1490-2. doi: 10.1111/j.1398-9995.2006.01197.x.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Angioedema / drug therapy*
  • Angioedema / genetics
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Bradykinin / analogs & derivatives*
  • Bradykinin / pharmacology
  • Bradykinin B2 Receptor Antagonists*
  • Humans
  • Middle Aged

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Bradykinin B2 Receptor Antagonists
  • icatibant
  • Bradykinin